https://www.live-feeds.com/feed/zap-you-re-gone-a-dana-farber-oncologist-discusses-the-promising-news-on-cancer-vaccinesContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/zap-you-re-gone-a-dana-farber-oncologist-discusses-the-promising-news-on-cancer-vaccineshttps://www.live-feeds.com/feed/zap-you-re-gone-a-dana-farber-oncologist-discusses-the-promising-news-on-cancer-vaccines#u169822Mon, 02 Nov 2026 11:26:13 +0000An effective cancer vaccine has been developed following successful clinical trials involving a personalized mRNA melanoma vaccine and Keytruda by drug makers Merck and Cambridge-based Moderna. The findings mark a significant step forward for personalized cancer treatment, though further research and reviews remain necessary before the vaccine achieves widespread availability. Meanwhile, the National Institutes of Health announced plans to invest nearly two hundred million dollars into developing cancer vaccines beginning in December. Scientists now face the question of how broadly the success